Founders

Dr. Khalid A. Alsulaiman is a Critical Care Pharmacotherapy Consultant and Clinical Associate Professor. He serves as Program Director of the Critical Care Pharmacy Residency at King Abdulaziz Medical City and Vice Chairman of Clinical Trial Management at King Abdullah International Medical Research Center (KAIMRC).

His academic foundation is built on advanced training from globally recognized institutions. He holds American Board certifications in Critical Care (BCCCP) and Nutrition Support (BCNSP), is a Fellow of the American College of Critical Care Medicine (FCCM), and is a graduate of the Harvard Global Clinical Scholars Research Training (GCSRT) Program. He also holds a Master of Business Administration (MBA). Dr. Alsulaiman seamlessly combines clinical excellence with a deep commitment to advancing research, education, and multidisciplinary collaboration in healthcare.

Dr. Alsulaiman has published more than 130 peer-reviewed articles, authored several books, and currently serves as Editor-in-Chief of The SCAPE Journal for Multidisciplinary Research. He is a peer reviewer for several high-impact journals and for the ACCP Critical Care Prep Course. He was recently inducted into the prestigious Sigma Xi scientific research honor society.

Dr. Alsulaiman’s visionary leadership extends beyond research into shaping the future of research and innovation. He is the founder of the Saudi Critical Care Pharmacy Research (SCAPE) Platform — the first pharmacist-led multidisciplinary research platform in the region. The platform fosters a sustainable research culture, strengthens existing infrastructure, and empowers researchers by highlighting the power of collaborative, multidisciplinary efforts. His visionary leadership also led to the establishment of the Saudi Society of Multidisciplinary Research Development and Education (SCAPE Society), where he serves as a key founder, Chairman of the Board, and the Chief Executive Officer (CEO). The SCAPE Society has set a clear and ambitious vision: to lead in fostering innovators and researchers, cultivate a vibrant culture of research, and catalyze innovation across diverse medical specialties. Through this initiative, the Society aims to empower a new generation of distinguished, creative researchers and innovators who will contribute to a brighter future for Saudi Arabia and the global community, while elevating the Kingdom’s standing as a leading global hub for research and innovation.

Dr. Ohoud Aljuhani, a distinguished faculty member in Pharmacy Practice specializing in critical care pharmacotherapy, stands as a beacon of innovation and leadership in her field. As a Consultant Critical Care Pharmacist with over a decade of experience, Dr. Aljuhani has left an indelible mark on critical care pharmacy.

Following ASHP-accredited residencies and a post-doctoral fellowship at the University of Arizona Medical Center, Dr. Aljuhani co-founded the Critical Care Pharmacy Research Platform. This groundbreaking initiative, recognized with the Jeddah Innovative Award for Digital Transformation, exemplifies her dedication to pioneering digital solutions and collaborative, multidisciplinary research.

Dr. Aljuhani's visionary leadership extends beyond the realms of research to teaching and mentorship, where she plays a pivotal role in shaping the future of pharmacy. Her expertise spans diverse critical care domains, including trauma management, pain, sedation, and ICU delirium.

Acknowledged for her exceptional contributions, Dr. Aljuhani has received prestigious accolades such as the ACCP 2015 Annual Meeting Resident/Fellow Award. She is a sought-after speaker at national and international conferences, advocating for critical care topics and fostering interdisciplinary dialogue.

In academia, Dr. Aljuhani's impact transcends traditional boundaries. She serves not only as an educator but also as a mentor, guiding and inspiring aspiring pharmacists and researchers. Her unwavering commitment to innovation and collaboration underscores her mission to advance the medical practice and enhance patient care outcomes.